XLS Medical Appetite Reducer - Appetite Suppressant and Hunger Control for a more Efficient Weight Loss - 60 Capsules, 10 Days Treatment

Product Information

No, you don’t need to head to your computer to compress a PDF file. With PDF2Go you can do this - you guessed it - on the go. Each bmiSMART product complex has been tested for safety and efficacy, including placebo-controlled, randomised human clinical trials published in peer-reviewed, indexed journals. 3 A spectrum of weight management solutions National Institute for Health and Care Excellence, Weight Management: Lifestyle Services for Overweight or Obese Results. Public Health Guideline, National Institute for Health and Care Excellence, London, UK, May 2014.

Whether they contain tables or images or plain text, with PDF2Go you can compress them fast and easily. Documents: In addition, a combination of dehydrated okra pod powder and inulin, the active ingredients in IQP-AE-103, has been shown to be a strong fat-binding agent in an in vitro setting simulating in vivo conditions (data not shown); it also exerts high swelling capacity and significantly enhances solution viscosity. Thus, IQP-AE-103 appears to be a promising natural agent that may help to control calorie intake, decrease absorption of dietary fat, and consequently lead to body weight reduction. Unfortunately, although obesity stems from consuming more calories than the body burns, more than 80% of overweight and obese individuals have trouble losing and maintaining weight loss through diet and exercise alone. These individuals recognise the serious health consequences of being overweight and often undertake drastic measures, including drug therapies and invasive surgeries, to achieve a healthier weight. Non-invasive weight management solutionsThere are many factors contributing to overweight or obesity such as physical inactivity, poor diet, high calorie intake, genetics, or the way the body uses energy. Hence, reducing body weight and calorie intake, introducing balanced diet, and increasing physical activity are critical to achieve weight loss. Pharmaceutical drug therapies are indicated when lifestyle intervention alone is unsuccessful. However, the vast majority of the currently available therapies are associated with unpleasant or even serious adverse effects. Many anti-obesity drugs that have been approved by health authorities have eventually been withdrawn from the market due to serious adverse events, for example, sibutramine or rimonabant, leaving limited options, for example, orlistat. But orlistat has also a long list of side effects, such as fecal incontinence, oily spotting, diarrhea, or even more severe side effects such as serious liver injury [ 14– 16]. Since weight loss is a long-term treatment, anti-obesity medications should have good tolerability and be free of side effects. For this reason, new strategies have to be developed to combat this complex health condition. Hunger Buddy by XLS is a medical device. Only recommended for adults over 18 years of age. The use of this product by adolescents 12-18 years old is subject to the supervision of healthcare professionals. This product must be taken as a whole capsule with a full glass of water (approximately 250 ml). Do not open the capsule and avoid taking in powder form to avoid choking. Please read the enclosed product insert before use. It is recommended to drink at least 2 litres of water a day. Slight constipation could occur in case of limited liquid intake. Do not take during pregnancy or whilst breastfeeding, or if your BMI is below 18.5. Consult your healthcare professional before taking this product if you have any medical condition or if you are diabetic. Keep out of reach and sight of children. Please read the enclosed product insert before use. Product Specification For you, we are running many services free of cost. Those services are expensive to run, requiring multiple servers to process and encode the files. Based on the physicochemical properties of okra pods and inulin, and the fat binding capacity shown in vitro, it was hypothesized that a product containing powdered okra pods and inulin could potentially contribute to weight loss. Hence, the primary objective of this randomised, double-blind, placebo-controlled clinical study was to evaluate the weight loss potential of IQP-AE-103 over the period of 12 weeks in overweight and moderately obese subjects. In this study, it was demonstrated that in conjunction with a hypocaloric diet, IQP-AE-103 at both low dose (990 mg okra and 255 mg inulin/day) and high dose (1980 mg okra and 510 mg inulin/day) causes significant weight loss and that the effects are greater than those in the placebo. Baseline body weight was reduced by 5.03 ± 2.50 kg in the high-dose group and by 3.01 ± 2.19 kg in the low-dose group, compared with 0.98 ± 2.06 kg in the placebo group. Also, for the high-dose group, weight loss effect due to IQP-AE-103 consumption was observed as early as at 2 weeks of treatment and was sustained over the course of the 12-week intake period. More importantly, the proportion of subjects who lost at least 5% of baseline body weight was 60.0% in the high-dose IQP-AE-103 group, a proportion that is significantly higher than that in the low-dose and the placebo groups. Such weight loss due to the intake of IQP-AE-103 is considered to be of clinical relevance as European Medicines Agency associates a weight loss of 5% or more with a decrease of disease risk factors associated with overweight and obesity [ 38]. Subgroup analysis showed that although both IQP-AE-103 high- and low-dose consumptions led to significant weight loss in overweight subjects, for moderately obese subjects, only high dose caused a significant body weight reduction. Subgroup analysis also showed a statistically significant weight loss in both high- and low-dose IQP-AE-103 groups in subjects aged 41–65 years when compared with placebo group, whereas only the high-dose group showed a significant weight loss versus placebo in subjects aged 18–40 years. Clinical data on plant-based oral solutions show non-invasive weight management can be effective and sustainable

Figure 2: Litramine 14-week placebo-controlled, randomised, double-blind clinical trial results Weight loss through digestive enzyme inhibition Hunger Buddy is clinically proven to promote significant weight loss through a reduced food intake. It is particularly suitable for those who constantly have a big appetite and cannot control portion size. Hunger Buddy is a certified medical device product for the treatment and All XLS-Medical products carry the CE logo, indicating they have been assessed to meet high safety, health, and environmental protection requirements In the next step, the weight loss and weight maintenance efficacy of IQP-AE-103 should be evaluated in longer clinical trials. Also, it would be worthwhile to further investigate any positive effect on cardiovascular risk factors associated with obesity, particularly in subjects with elevated blood lipids. For further elucidation of mode of action, an assessment of fecal fat excretion, or postprandial blood lipid changes and potentially gut microbiome study could be considered. 5. Conclusion and ImplicationFigure 3: Tanitol 14-week placebo-controlled, randomised, double-blind clinical trial results Weight loss through increased satiety

The resulting plant-based compound reduces dietary fat absorption through gastrointestinal fat binding, and has been shown to bind dietary fat at a level previously only achieved by prescription drugs, but without the undesirable side-effects. 4 Plants have always been a good source of new potential and natural therapies for illnesses, including body weight management products. Litramine®, a natural fibre complex derived from Opuntia ficus-indica, enriched with soluble fibres from Acacia sp., has been shown in a number of clinical trials to safely and effectively reduce and maintain weight loss [ 17– 20]. Litramine® has been demonstrated to reduce dietary fat absorption and increase fecal fat excretion, resulting in lower calorie absorption from diet, which leads to weight loss [ 20, 21]. if they have any follow up questions or if they need to discuss the use of this medicine with you. Please note that we reserve the right to decline supply if No significant differences in changes of feeling of fullness and food cravings between the study arms were observed. However, feeling of hunger decreased in 66% of subjects in the high-dose group (statistically significant pre-post change). This may be related to the swelling property of okra pods reported earlier [ 22]. Okra constituents such as soluble fibre or polysaccharides may increase viscosity of taken meal and form a gel, thus increasing gastric distension and thereby promoting satiety [ 45]. XLS Medical Appetite Reducer belongs to a clinically proven and innovative range of weight management products scientifically developed for a healthier and balanced lifeProprietary ingredient clinically shown to increase satiety and support significant weight loss in overweight and obese adults Institute of Medicine, Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients), The National Acadamy Press, Washington, DC, USA, 2005. For beneficial action of fibres on gastrointestinal transit, it is recommended to drink at least 2L of water a day. Slight constipation could occur in case of limited liquid intake. If constipation persists despite adequate fluid intake, please consult your healthcare professional.